CCL5 and neoplasm: This immunomodulatory effect was not restricted to oxaliplatin, other platinum-based drugs, such as carboplatin, have also increased tumor CD8+ T cell populations and enhanced CCL5 and CXCL10 mRNA levels in lung cancer cells (46).